Pfizer’s $6 Billion Acquisition: A Game-Changer in Cancer Treatment?
Pfizer's acquisition of a cancer drug from 3SBio could redefine oncology.
Pfizer's acquisition of a cancer drug from 3SBio could redefine oncology.
Mark Cuban discusses how Trump's healthcare order could lead to pharmaceutical savings.
Pfizer halts weight loss pill development after a liver injury raises safety concerns.
Pfizer's COVID vaccine announcement timing is under investigation for potential political motivations.
Zepbound sales surge while Ozempic faces tariff threats. Discover the latest in pharmaceutical news.
Explore the turbulent landscape of vaccines amid CDC-WHO divergence and new threats.